Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02821104 · ClinicalTrials.gov registry record
Complement and Cardiovascular Risk in Adolescents
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 77
- Enrollment target
NCT02821104: Completed study, sponsored by Ohio State University.
NCT02821104 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02821104 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
This study evaluates how genetic variations in complement, a part of the immune system, affect cardiovascular risk in adolescents.
Primary Outcome
Genetic C3F genotype allele presence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-06-30 |
What the finished NCT02821104 record still lists
NCT02821104 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02821104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02821104 about?
NCT02821104 is a clinical study titled "Complement and Cardiovascular Risk in Adolescents". This study evaluates how genetic variations in complement, a part of the immune system, affect cardiovascular risk in adolescents.
What is the current status of trial NCT02821104?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2016-06. Estimated completion is 2018-06-30.
Who is sponsoring clinical trial NCT02821104?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia